• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较精神科医生和患者对长效注射抗精神病药物的态度。

Comparison of attitudes toward long-acting injectable antipsychotics among psychiatrists and patients.

机构信息

Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea.

出版信息

Int Clin Psychopharmacol. 2013 Mar;28(2):80-6. doi: 10.1097/YIC.0b013e32835d30ae.

DOI:10.1097/YIC.0b013e32835d30ae
PMID:23325306
Abstract

The current prescription rate of long-acting injectable antipsychotics (LAI) is less than 1% in Korea. This study aimed to investigate the reason for LAI underuse by surveying the attitudes toward LAI among psychiatrists and patients receiving LAI. A total of 173 psychiatrists and 99 patients receiving LAI participated in the survey. Participating psychiatrists were divided into two groups according to experience with prescribing LAI to at least 10 patients. The two psychiatrist groups did not differ significantly in terms of sociodemographic characteristics and clinical practice patterns. However, the group with higher experience more frequently provided explanations of LAI to their patients and was more satisfied with the use of LAI than the group with less experience. Acceptance rates of patients to the recommendation for LAI treatment and satisfaction of psychiatrists with the outcome of LAI were also significantly higher in the group with higher experience. Psychiatrists with less experience with LAI were more negative toward LAI than patients receiving LAI as well as psychiatrists with higher experience. In conclusion, attitudes of psychiatrists toward LAI were closely related to the use of LAI. The negative attitude and reluctance of psychiatrists, rather than patient resistance, may contribute toward the underuse of LAI.

摘要

韩国目前长效注射抗精神病药(LAI)的处方率不足 1%。本研究旨在通过调查接受 LAI 治疗的精神科医生和患者对 LAI 的态度,探讨 LAI 使用率低的原因。共有 173 名精神科医生和 99 名接受 LAI 的患者参与了这项调查。参与调查的精神科医生根据至少为 10 名患者开具 LAI 的经验分为两组。两组精神科医生在社会人口统计学特征和临床实践模式方面没有显著差异。然而,经验更丰富的组更频繁地向患者解释 LAI,并比经验较少的组对 LAI 的使用更满意。经验更丰富组的患者对 LAI 治疗建议的接受率和精神科医生对 LAI 治疗结果的满意度也显著更高。与接受 LAI 治疗的患者以及经验更丰富的精神科医生相比,经验较少的精神科医生对 LAI 的态度更为消极。总之,精神科医生对 LAI 的态度与 LAI 的使用密切相关。精神科医生的消极态度和不情愿,而不是患者的抵触,可能是导致 LAI 使用率低的原因。

相似文献

1
Comparison of attitudes toward long-acting injectable antipsychotics among psychiatrists and patients.比较精神科医生和患者对长效注射抗精神病药物的态度。
Int Clin Psychopharmacol. 2013 Mar;28(2):80-6. doi: 10.1097/YIC.0b013e32835d30ae.
2
Clinicians' attitudes toward the use of long-acting injectable antipsychotics.临床医生对使用长效注射用抗精神病药物的态度。
J Nerv Ment Dis. 2013 Jul;201(7):553-9. doi: 10.1097/NMD.0b013e31829829c4.
3
Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.精神科医生对第一代和第二代抗精神病长效注射剂的使用、知识和态度:5 年的比较。
J Psychopharmacol. 2010 Oct;24(10):1473-82. doi: 10.1177/0269881109104882. Epub 2009 May 28.
4
Explicit review of risperidone long-acting injection prescribing practice.利培酮长效注射剂处方实践的明确审查。
J Clin Pharm Ther. 2011 Dec;36(6):651-63. doi: 10.1111/j.1365-2710.2010.01219.x. Epub 2010 Nov 5.
5
Barriers to utilizing long-acting injectable antipsychotic medications.使用长效注射用抗精神病药物的障碍。
Ann Clin Psychiatry. 2014 Feb;26(1):33-8.
6
Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia.患者及处方者对长效注射用抗精神病药物的看法以及关于精神分裂症长效注射治疗的门诊讨论分析
BMC Psychiatry. 2013 Oct 16;13:261. doi: 10.1186/1471-244X-13-261.
7
Barriers to utilizing long-acting injectable antipsychotic medications.使用长效注射用抗精神病药物的障碍。
Ann Clin Psychiatry. 2013 Nov;25(4):E1-6.
8
A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives.一项关于长效注射抗精神病药的体验和认知的定性研究:第二部分——医生观点。
Can J Psychiatry. 2013 May;58(5 Suppl 1):23S-9S. doi: 10.1177/088740341305805s04.
9
Checking the plausibility of psychiatrists׳ arguments for not prescribing depot medication.检查精神科医生提出的不处方长效药物的论点的合理性。
Eur Neuropsychopharmacol. 2014 Sep;24(9):1506-10. doi: 10.1016/j.euroneuro.2014.06.015. Epub 2014 Jul 4.
10
[French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].[法国生物精神病学与神经精神药理学协会特别工作组:长效抗精神病药物处方的正式共识]
Encephale. 2013 Dec;39 Suppl 4:189-203. doi: 10.1016/S0013-7006(13)70121-0.

引用本文的文献

1
Long-Acting Injectable Antipsychotic Treatment for Schizophrenia in Asian Population: A Scoping Review.亚洲人群中长效注射用抗精神病药物治疗精神分裂症的范围综述
Neuropsychiatr Dis Treat. 2023 Sep 18;19:1987-2006. doi: 10.2147/NDT.S413371. eCollection 2023.
2
Effectiveness of Switching to Long-acting Injectable Aripiprazole in Patients with Recent-onset and Chronic Schizophrenia.近期发病及慢性精神分裂症患者换用长效注射用阿立哌唑的疗效
Clin Psychopharmacol Neurosci. 2023 Feb 28;21(1):57-67. doi: 10.9758/cpn.2023.21.1.57.
3
Antipsychotic-Related Stigma and the Impact on Treatment Choices: A Systematic Review and Framework Synthesis.
抗精神病药物相关的污名化及其对治疗选择的影响:一项系统综述与框架综合分析
Patient Prefer Adherence. 2022 Feb 16;16:373-401. doi: 10.2147/PPA.S343211. eCollection 2022.
4
The Willingness of Community Psychiatric Management Physicians to Preferentially Recommend Long-Acting Injections in Beijing.北京市社区精神科医生优先推荐长效注射剂的意愿。
Front Public Health. 2021 Nov 19;9:779563. doi: 10.3389/fpubh.2021.779563. eCollection 2021.
5
Positive views on antipsychotic long-acting injections: results of a survey of community patients prescribed antipsychotics.对抗精神病长效注射剂的积极看法:对开具抗精神病药物的社区患者的调查结果
Ther Adv Psychopharmacol. 2019 Jul 3;9:2045125319860977. doi: 10.1177/2045125319860977. eCollection 2019.
6
Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan.日本精神分裂症患者对长效注射用抗精神病药物的态度。
Neuropsychiatr Dis Treat. 2019 Jan 9;15:205-211. doi: 10.2147/NDT.S188337. eCollection 2019.
7
Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting.长效注射用抗精神病药物的适应证及应用:来自住院环境的考量
Int Clin Psychopharmacol. 2017 May;32(3):161-168. doi: 10.1097/YIC.0000000000000165.
8
Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics.精神分裂症治疗中的临床决策:聚焦长效注射用抗精神病药物
Int J Mol Sci. 2016 Nov 19;17(11):1935. doi: 10.3390/ijms17111935.
9
Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region.亚太地区近期发病精神病患者的最佳护理建议。
Asia Pac Psychiatry. 2016 Jun;8(2):154-71. doi: 10.1111/appy.12234.
10
The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.长效注射用抗精神病药在精神分裂症中的作用:批判性评价。
Ther Adv Psychopharmacol. 2014 Oct;4(5):198-219. doi: 10.1177/2045125314540297.